Product
Weekly rifapentine and isoniazid
1 clinical trial
3 indications
Indication
HIVIndication
TuberculosisIndication
Household ContactClinical trial
A Randomized Trial Comparing Treatment Completion of Daily Rifapentine & Isoniazid for One Month (1HP) To Weekly Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in HIV-negative Household Contacts of Recently Diagnosed Tuberculosis Patients, The "One To Three" TrialStatus: Recruiting, Estimated PCD: 2024-10-28